IMPORTANT INFORMATION

S2Medical AB (publ) ("the Company") has, due to legal restrictions, limited the availability of this part of the website. We therefore ask you to take note of the following information and provide the following confirmation each time you wish to access these web pages. Please note that the terms and conditions below may be changed or updated, and it is therefore important that you read them each time you visit this site.

The information on this part of the Company's website is not intended for, and may not, directly or indirectly, in whole or in part, be accessed by or distributed or disseminated to persons residing or located in the United States (including its territories and possessions, any state of the United States and the District of Columbia) ("United States"), the United Kingdom, Canada, Japan, Australia, Hong Kong, New Zealand, Switzerland, South Africa or any other jurisdiction where such action is subject in whole or in part to legal restrictions, or would require additional prospectuses, registration or other measures than those required by Swedish law. The information on the Websites does not constitute an offer of shares, unit rights, paid-up subscribed units or units issued by the Company ("Securities") to any person in the said jurisdictions. Nor may the information on the web pages be transmitted or reproduced in a manner that is contrary to such restrictions or would impose such requirements.

No Securities have been or will be registered under the United States Securities Act of 1933, as amended, or the securities laws of any state or other jurisdiction of the United States and may not be offered, subscribed, exercised, pledged, sold, resold, assigned, delivered or otherwise transferred, directly or indirectly, in or into the United States, except pursuant to any exemptions accepted by the Company.

The Company reserves the right, subject to any relevant exemption, to accept subscriptions from a person located or resident in a jurisdiction where participation would otherwise require additional prospectuses, registration, or other measures other than those required by Swedish law.

Within the European Economic Area ("EEA"), no offer to the public of Securities will be made in any country other than Sweden. In other member states of the European Union ("EU"), such an offer may only be made in accordance with the exemptions in the Prospectus Regulation (EU) 2017/1129 (the "Prospectus Regulation"). In other EEA countries that have implemented the Prospectus Regulation into national law, such an offer may only be made in accordance with the exemption in the Prospectus Regulation and in accordance with any relevant implementing measure. In other EEA countries that have not implemented the Prospectus Regulation into national law, such an offer may only be made in accordance with the applicable exemption in national law.

To access the information on this part of the Company's website, all persons must first ensure that they are not subject to any legal restrictions limiting their ability to access the information on this part of the Company's website.

We therefore ask you to confirm that you are resident, or located, outside the United States, the United Kingdom, Canada, Japan, Australia, Hong Kong, New Zealand, Switzerland, South Africa or any other jurisdiction where such action is subject in whole or in part to legal restrictions, or would require additional prospectus, registration or other action other than that required by Swedish law and are entitled to access the information on these web pages without restriction by law or regulation and without the requirement that any additional action be taken by the Company. We also ask you to confirm that you have read the information, terms and restrictions above and that you agree to abide by them.

By accepting below, I confirm that I have read the above instructions and the terms and conditions provided on this part of the website.